Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice
- PMID: 33837189
- PMCID: PMC8035190
- DOI: 10.1038/s41467-021-22295-w
Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice
Abstract
Prime editors (PEs) mediate genome modification without utilizing double-stranded DNA breaks or exogenous donor DNA as a template. PEs facilitate nucleotide substitutions or local insertions or deletions within the genome based on the template sequence encoded within the prime editing guide RNA (pegRNA). However, the efficacy of prime editing in adult mice has not been established. Here we report an NLS-optimized SpCas9-based prime editor that improves genome editing efficiency in both fluorescent reporter cells and at endogenous loci in cultured cell lines. Using this genome modification system, we could also seed tumor formation through somatic cell editing in the adult mouse. Finally, we successfully utilize dual adeno-associated virus (AAVs) for the delivery of a split-intein prime editor and demonstrate that this system enables the correction of a pathogenic mutation in the mouse liver. Our findings further establish the broad potential of this genome editing technology for the directed installation of sequence modifications in vivo, with important implications for disease modeling and correction.
Conflict of interest statement
UMass has filed a patent application on PE2* and AAT pegRNAs in this work (inventors: P.L., S.Q.L., S.A.W., and W.X., patent filed/pending). S.A.W. is a consultant for Chroma Medicine. All remaining authors declare that the research was conducted in the absence of a commercial or financial conflict of interest. The authors declare no competing non-financial interests.
Figures





Similar articles
-
Template-jumping prime editing enables large insertion and exon rewriting in vivo.Nat Commun. 2023 Jun 8;14(1):3369. doi: 10.1038/s41467-023-39137-6. Nat Commun. 2023. PMID: 37291100 Free PMC article.
-
Evolution of Prime Editing Systems: Move Forward to the Treatment of Hereditary Diseases.Curr Gene Ther. 2025;25(1):46-61. doi: 10.2174/0115665232295117240405070809. Curr Gene Ther. 2025. PMID: 38623982 Review.
-
Engineering Oncogenic Hotspot Mutations on SF3B1 via CRISPR-Directed PRECIS Mutagenesis.Cancer Res Commun. 2024 Sep 1;4(9):2498-2513. doi: 10.1158/2767-9764.CRC-24-0145. Cancer Res Commun. 2024. PMID: 39194178 Free PMC article.
-
Selection of Optimal pegRNAs to Enhance Efficiency of Prime Editing in AT-Rich Genome Regions.Biochemistry (Mosc). 2025 Jun;90(6):773-785. doi: 10.1134/S0006297924604672. Biochemistry (Mosc). 2025. PMID: 40609995
-
Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy.Hum Gene Ther. 2024 Oct;35(19-20):781-797. doi: 10.1089/hum.2024.020. Hum Gene Ther. 2024. PMID: 39276086 Review.
Cited by
-
Advancing CRISPR base editing technology through innovative strategies and ideas.Sci China Life Sci. 2025 Mar;68(3):610-627. doi: 10.1007/s11427-024-2699-5. Epub 2024 Sep 2. Sci China Life Sci. 2025. PMID: 39231901 Review.
-
Engineered CRISPR prime editors with compact, untethered reverse transcriptases.Nat Biotechnol. 2023 Mar;41(3):337-343. doi: 10.1038/s41587-022-01473-1. Epub 2022 Sep 26. Nat Biotechnol. 2023. PMID: 36163548 Free PMC article.
-
CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.Adv Drug Deliv Rev. 2022 Feb;181:114087. doi: 10.1016/j.addr.2021.114087. Epub 2021 Dec 20. Adv Drug Deliv Rev. 2022. PMID: 34942274 Free PMC article. Review.
-
CRISPR applications in cancer diagnosis and treatment.Cell Mol Biol Lett. 2023 Sep 6;28(1):73. doi: 10.1186/s11658-023-00483-4. Cell Mol Biol Lett. 2023. PMID: 37674114 Free PMC article. Review.
-
Template-jumping prime editing enables large insertion and exon rewriting in vivo.Nat Commun. 2023 Jun 8;14(1):3369. doi: 10.1038/s41467-023-39137-6. Nat Commun. 2023. PMID: 37291100 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials